Abstract, Snapshot, Market Analysis & Market Definition: World Circulating Tumor Cells Market
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.
In 2018, the global Circulating Tumor Cells market size was 880.7 million US$ and it is expected to reach 3230 million US$ by the end of 2025, with a CAGR of 20.4% during 2019-2025.This report focuses on the global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells development in United States, Europe and China
Market Segmentation, Outlook & Viewpoint: World Circulating Tumor Cells Market
Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: CTC Enrichment
CTC Detection
CTC Analysis
Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Top Companies & Key Players: World Circulating Tumor Cells Market
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Key Insights Covered: World Circulating Tumor Cells Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Circulating Tumor Cells industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Circulating Tumor Cells industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Circulating Tumor Cells industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Circulating Tumor Cells industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Circulating Tumor Cells industry.
Research Methodology: Global Circulating Tumor Cells Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.